EAR Customized Hearing Protection Explores How SoundGear Phantom and Digital Technology Transform Shooter Safety
Press Advantage
Today at 9:03pm UTC
JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
PR Newswire
Today at 9:03pm UTC
JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
PR Newswire
Today at 9:02pm UTC
A Plus Garage Door Repair Announces Service Program Update for Springville Operations
Press Advantage
Today at 8:40pm UTC
AT&T to Release Second-Quarter 2026 Earnings on July 22
PR Newswire
Today at 8:30pm UTC
A Plus Garage Door Repair Announces Summer Safety Inspection Special for Logan Homeowners
PressAdvantage
Today at 8:20pm UTC
Fathom Holdings Inc. Receives Notification from Nasdaq Regarding Late Filing of Form 10-Q
PR Newswire
Today at 8:05pm UTC
822 Heat & Air Expands Commercial AC Service Throughout Dallas-Fort Worth Metroplex
PressAdvantage
Today at 8:02pm UTC
RestoPros of Southern New Hampshire Responds to Surge in Spring Sump Pump Failures
PressAdvantage
Today at 8:02pm UTC
Kreditsearch.ch Enhances Swiss Personal Loan Comparison Platform with Expanded Resources
PressAdvantage
Today at 8:02pm UTC
A Plus Garage Door Repair Announces Extended Service Program Through July 2026
PressAdvantage
Today at 8:02pm UTC
Sidus Space Announces Closing of Offering
PR Newswire
Today at 8:01pm UTC
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
PR Newswire
Today at 8:01pm UTC
A Plus Garage Door Repair Announces Extended Installation Program Through July 2026
PressAdvantage
Today at 7:41pm UTC
A Plus Garage Door Repair Announces Extended Installation Program for Washington Utah Residents
PressAdvantage
Today at 7:40pm UTC
Edge to Edge Home Flooring Highlights Premium Flooring Solutions for Berkshire Home Improvement Projects
PressAdvantage
Today at 7:24pm UTC
Better Hearing and Whole-Body Health: What to Know About MRI Access with Cochlear Implants
PR Newswire
Today at 6:13pm UTC
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical...
PR Newswire
Today at 6:00pm UTC
Mynd.ai Regains Compliance with NYSE American Filing Requirements Following Submission of Annual Report on Form 20-F
PR Newswire
Today at 6:00pm UTC
GetHookd Meta Ad Creative Analyzer With Competitor Intelligence: Platform Update
NewsNetwork
Today at 5:55pm UTC